SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-15-051840
Filing Date
2015-08-26
Accepted
2015-08-25 19:23:47
Documents
1
Group Members
VIVEK RAMASWAMY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 v419010_sc13da1.htm SC 13D/A 50436
  Complete submission text file 0001144204-15-051840.txt   52145
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 151074470
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 215-489-4928
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0315
Type: SC 13D/A